Distinction between bacterial and viral infections by serum measurement of human neutrophil lipocalin (HNL) and the impact of antibody selection
Authors:
- 1 May 2016
- journal article
- research article
- Published by Elsevier in Journal of Immunological Methods
- Vol. 432, 82-86
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Antibiotic Resistance — Problems, Progress, and ProspectsNew England Journal of Medicine, 2014
- Usefulness of C-reactive protein testing in acute cough/respiratory tract infection: an open cluster-randomized clinical trial with C-reactive protein testing in the intervention groupBMC Family Practice, 2014
- Antibiotic resistance—the need for global solutionsThe Lancet Infectious Diseases, 2013
- Immunoassays distinguishing between HNL/NGAL released in urine from kidney epithelial cells and neutrophilsClinica Chimica Acta, 2012
- The Origin of Multiple Molecular Forms in Urine of HNL/NGALClinical Journal of the American Society of Nephrology, 2010
- Neutrophil gelatinase-associated lipocalin in adult septic patients with and without acute kidney injuryIntensive Care Medicine, 2010
- Assays of urine levels of HNL/NGAL in patients undergoing cardiac surgery and the impact of antibody configuration on their clinical performancesClinica Chimica Acta, 2009
- Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgeryThe Lancet, 2005
- Serum measurements of human neutrophil lipocalin (HNL) discriminate between acute bacterial and viral infectionsScandinavian Journal of Clinical and Laboratory Investigation, 1995
- Purification and characterization of a human neutrophil lipocalin (HNL) from the secondary granules of human neutrophilsScandinavian Journal of Clinical and Laboratory Investigation, 1994